Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) EPS (Basic): 2020-2025

Historic EPS (Basic) for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $0.08.

  • Cellebrite DI's EPS (Basic) rose 108.07% to $0.08 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.33, marking a year-over-year increase of 120.87%. This contributed to the annual value of -$1.35 for FY2024, which is 213.95% down from last year.
  • Per Cellebrite DI's latest filing, its EPS (Basic) stood at $0.08 for Q3 2025, which was up 2.32% from $0.08 recorded in Q2 2025.
  • Cellebrite DI's 5-year EPS (Basic) high stood at $0.29 for Q1 2022, and its period low was -$1.04 during Q3 2024.
  • For the 3-year period, Cellebrite DI's EPS (Basic) averaged around -$0.15, with its median value being -$0.08 (2023).
  • In the last 5 years, Cellebrite DI's EPS (Basic) soared by 3,024.76% in 2021 and then plummeted by 3,112.78% in 2024.
  • Over the past 5 years, Cellebrite DI's EPS (Basic) (Quarterly) stood at $0.29 in 2021, then crashed by 86.59% to $0.04 in 2022, then crashed by 297.98% to -$0.08 in 2023, then skyrocketed by 220.75% to $0.09 in 2024, then spiked by 108.07% to $0.08 in 2025.
  • Its EPS (Basic) stands at $0.08 for Q3 2025, versus $0.08 for Q2 2025 and $0.07 for Q1 2025.